Skip to main content
BrainCited

Alpha-GPC 관련 Age-Related Cognitive Decline

C

Research suggests Alpha-GPC may support cognitive function in elderly populations with age-related decline. It is used as a prescription drug in Europe for cognitive impairment, with studies showing improvements in cognitive function scores.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dalpha\u002Dgpc\u0026condition\u003Dcognitive\u002Ddecline'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  




    








    

        

            C

        

        

            
결론

            
            
Research suggests Alpha-GPC may support cognitive function in elderly populations with age-related decline. It is used as a prescription drug in Europe for cognitive impairment, with studies showing improvements in cognitive function scores.

            
            
        

    










    

  
Key Study Findings





    

        
        

            

                
                    Randomized Controlled Trial
                
                
                
                
            

            
                Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized …
            
            

                
                Dose: None
                
                
                vs: None
                
                
                Outcome: Cognitive decline
                
                
                효과: None
                
                
                None
                
            

            
            
대상 집단: Alzheimer's disease patients

            
        

        
    







    
    

        
        

            

  
Key Statistics





            


    

        
8

        
연구

    

    

        
600

        
참여자

    

    

        
            
            ↑
            
        
        
Positive

    

    

        C

        
등급

    




        


        
        
        

            

  
Referenced Papers





            

                
                

                    

                        
                            Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial.
                        
                        
                            
                                RCT
                            
                            
                            
                        
                    

                    

                        Medicine
                        2024
                        
                        3 인용
                        
                    

                

                
            

        

        

        
        
        

            

  
Dosage & Usage





            
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units


            
            

                
일반적으로 사용되는 용량

                

                    
                    

                        
general:

                        
300-600 mg/day

                    

                    
                    

                        
cognitivesupport:

                        
600-1,200 mg/day

                    

                    
                

                
                

                    상한량: Not established; well-tolerated up to 1,200 mg/day
                

                
            

            

            
            

                
연구에서 사용된 용량

                

                    

                        
                            

                                용량
                                기간
                                효과
                                N
                            

                        
                        
                            
                            

                                None
                                --
                                
                                    
                                    Positive
                                    
                                
                                --
                            

                            
                        
                    

                

            

            

            
            

                권장 복용 시간: Morning or split dose; with or without food
            

            
        

        

        
        
        

            

  
Safety & Side Effects





            

                
                

                    
보고된 부작용

                    
    
                        
                        
  • 
                            ⚠
                            Headache
                        
    • 
                        
                        
  • 
                            ⚠
                            Insomnia
                        
    • 
                        
                        
  • 
                            ⚠
                            Dizziness
                        
    • 
                        
                        
  • 
                            ⚠
                            Gastrointestinal discomfort
                        
    • 
                        
                        
  • 
                            ⚠
                            Fishy body odor at high doses (TMAO conversion)
                        
    • 
                        
                    

                

                

                
                

                    
알려진 상호작용

                    
    
                        
                        
  • 
                            ●
                            Anticholinergic medications (opposes Alpha-GPC effects)
                        
    • 
                        
                        
  • 
                            ●
                            Cholinesterase inhibitors (additive cholinergic effects)
                        
    • 
                        
                        
  • 
                            ●
                            Scopolamine (opposes cholinergic effects)
                        
    • 
                        
                    

                

                

                
                

                    

                        일일 최대 섭취 허용량: Not established; well-tolerated up to 1,200 mg/day
                    

                

                
            

            

                건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.
            

        

        

        
        
        

            

  
Frequently Asked Questions





            




    
    

        
            Does Alpha-GPC help with Age-Related Cognitive Decline?
            
        
        

            Based on 8 studies with 600 participants, there is limited but promising evidence that Alpha-GPC may support Age-Related Cognitive Decline management. Our evidence grade is C (Some Evidence).
        

    

    
    

        
            How much Alpha-GPC should I take for Age-Related Cognitive Decline?
            
        
        

            Studies have used various dosages. A commonly studied range is 300-600 mg/day. Always consult your healthcare provider before starting any supplement regimen.
        

    

    
    

        
            Are there side effects of Alpha-GPC?
            
        
        

            Reported side effects may include Headache, Insomnia, Dizziness, Gastrointestinal discomfort. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
        

    

    
    

        
            How strong is the evidence for Alpha-GPC and Age-Related Cognitive Decline?
            
        
        

            We rate the evidence as Grade C (Some Evidence). This rating is based on 8 peer-reviewed studies with 600 total participants. The overall direction of effect is positive.
        

    

    




        

        

        
        
        

            

  
Related Evidence





            

                
                
                

                
                

                    
Alpha-GPC 다른 건강 상태에 대한 근거

                    

                        
                        
                            Neurotransmitter Imbalance
                            B

                        
                        
                    

                

                
            

        

        

    


    
    












    

        FDA 면책 조항:
        이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.